Enovix Corporation vs Health Care Select Sector SPDR Fund — how do they compare? Enovix Corporation trades at $4.69 (market cap $1.11B), while Health Care Select Sector SPDR Fund trades at $161.62. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| ENVX | XLV | |
|---|---|---|
Market Cap | $1.11B | — |
Sector | Technology | — |
52-Week High | $15.93 | $164.48 |
52-Week Low | $4.84 | $129.01 |
Enterprise Value | $1.13B | — |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $4.855, down 4.05% today amid bearish technical signals. The company shows strong revenue growth potential with recent earnings beats but operates at a significant loss, reflected in a -499.64% net margin. Positive sentiment is driven by analyst consensus with a $12.75 price target and recent operational hires from Apple, though cash flow remains negative as production scales.
Outlook hinges on successful manufacturing ramp-up and smartphone battery qualification. High execution risk and cash burn present challenges, but leadership in silicon-anode technology offers long-term upside if commercial targets are met. Investors face volatility but potential reward from current discounted levels.
XLV trades at $161.67, up 2.14% with bullish technical momentum supported by moving averages. The healthcare ETF benefits from State Street's upgraded sector outlook and strong performance from holdings like Johnson & Johnson. Technical indicators show mixed signals with oversold RSI_6 but bearish oscillators, while support levels cluster around $156-158.
Outlook remains positive as healthcare gains defensive appeal amid market volatility. Key risks include sector rotation and patent cliff concerns, but institutional rotation into healthcare and innovation trends support long-term growth potential for diversified exposure.
Trailing returns across standard periods
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →